CSS
MED icon

Cubist Systematic Strategies’s Medifast MED Stock Holding History

Cubist Systematic Strategies’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-39,911
Closed -$2.99M – 3887
2023
Q3 		$2.99M Sell
39,911
-66,292
-62% -$5.88M 0.02% 1083
2023
Q2 		$9.79M Sell
106,203
-6,744
-6% -$600K 0.07% 443
2023
Q1 		$11.7M Buy
112,947
+63,069
+126% +$6.99M 0.07% 383
2022
Q4 		$5.75M Buy
49,878
+33,958
+213% +$3.95M 0.03% 890
2022
Q3 		$1.73M Buy
15,920
+12,581
+377% +$1.8M 0.01% 2155
2022
Q2 		$603K Sell
3,339
-8,977
-73% -$1.61M ﹤0.01% 2906
2022
Q1 		$2.1M Buy
12,316
+220
+2% +$41.5K 0.02% 1428
2021
Q4 		$2.53M Sell
12,096
-2,722
-18% -$563K 0.02% 1168
2021
Q3 		$2.85M Sell
14,818
-4,501
-23% -$1.11M 0.04% 786
2021
Q2 		$5.47M Sell
19,319
-2,891
-13% -$783K 0.06% 487
2021
Q1 		$4.71M Buy
22,210
+4,990
+29% +$1.19M 0.06% 485
2020
Q4 		$3.38M Sell
17,220
-3,657
-18% -$646K 0.05% 652
2020
Q3 		$3.43M Buy
20,877
+13,578
+186% +$2.24M 0.05% 588
2020
Q2 		$1.01M Sell
7,299
-20,308
-74% -$1.86M 0.02% 1169
2020
Q1 		$1.73M Buy
27,607
+12,010
+77% +$1.09M 0.05% 534
2019
Q4 		$1.71M Sell
15,597
-6,163
-28% -$596K 0.03% 838
2019
Q3 		$2.25M Sell
21,760
-993
-4% -$107K 0.04% 578
2019
Q2 		$2.92M Sell
22,753
-2,862
-11% -$398K 0.05% 510
2019
Q1 		$3.27M Buy
25,615
+4,760
+23% +$604K 0.11% 258
2018
Q4 		$2.61M Buy
20,855
+19,528
+1,472% +$3.34M 0.12% 183
2018
Q3 		$294K Buy
1,327
+133
+11% +$27K 0.02% 1172
2018
Q2 		$191K Sell
1,194
-4,691
-80% -$600K 0.01% 1371
2018
Q1 		$550K Buy
5,885
+460
+8% +$34.4K 0.03% 748
2017
Q4 		$379K Buy
+5,425
New +$360K 0.02% 1089

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's MED Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Medifast (MED) in Q4 2023, closing a stake of 39,911 shares — an estimated $2.99M sold.

Cubist Systematic Strategies first reported a position in MED in Q4 2017 and held it in 24 quarters. The position peaked at $11.7M in Q1 2023. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 39,911 Medifast shares in Q4 2023, an estimated $2.99M.
  • Cubist Systematic Strategies first reported a position in Medifast in Q4 2017 and held it in 24 quarters.
  • Cubist Systematic Strategies's Medifast position peaked at $11.7M in Q1 2023.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.